Venetoclax in the treatment of acute myeloid leukemia: Beyond VIALE-A

被引：1
|
作者：
Gangat, Naseema [1 ,2 ]
Tefferi, Ayalew [1 ,3 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Mayo Clin, Div Hematol, 200 First St SW, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Med, Div Hematol, 200 First St SW, Rochester, MN 5590 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2024年 / 99卷 / 04期
关键词：
PLUS HYPOMETHYLATING AGENT; AZACITIDINE; DECITABINE;
D O I：
10.1002/ajh.27256
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：515 / 518
页数：4
相关论文
共 50 条
  • [1] Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE-A
    Pratz, Keith W.
    DiNardo, Courtney D.
    Selleslag, Dominik
    Li, Junmin
    Yamamoto, Kazuhito
    Konopleva, Marina
    Stevens, Don
    Kantarjian, Hagop
    Traina, Fabiola
    Venditti, Adriano
    Mayer, Jiri
    Montez, Melissa
    Jin, Huan
    Duan, Yinghui
    Brackman, Deanna
    Zha, Jiuhong
    Potluri, Jalaja
    Werner, Michael
    Jonas, Brian A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (11) : E416 - E419
  • [2] The heart of VIALE-A: Cardiac complications of hypomethylating agents and venetoclax in acute myeloid leukaemia
    Patel, Shyam A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1137 - 1138
  • [3] Cytopenia Management in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax Plus Azacitidine in the VIALE-A Study
    Pratz, Keith W.
    DiNardo, Courtney D.
    Selleslag, Dominik
    Li, Junmin
    Yamamoto, Kazuhito
    Konopleva, Marina
    McDonald, Andrew
    Babu, Sunil
    Stevens, Don A.
    Kantarjian, Hagop M.
    Traina, Fabiola
    Venditti, Adriano
    Mayer, Jiri
    Montez, Melissa
    Ramsingh, Giridharan
    Jin, Huan
    Ainsworth, William
    Duan, Yinghui
    Svensson, Anders Erik
    Werner, Michael
    Potluri, Jalaja
    Jonas, Brian A.
    BLOOD, 2020, 136
  • [4] Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia
    Pratz, Keith W.
    Jonas, Brian A.
    Pullarkat, Vinod
    Thirman, Michael J.
    Garcia, Jacqueline S.
    Doehner, Hartmut
    Recher, Christian
    Fiedler, Walter
    Yamamoto, Kazuhito
    Wang, Jianxiang
    Yoon, Sung-Soo
    Wolach, Ofir
    Yeh, Su-Peng
    Leber, Brian
    Esteve, Jordi
    Mayer, Jiri
    Porkka, Kimmo
    Illes, Arpad
    Lemoli, Roberto M.
    Turgut, Mehmet
    Ku, Grace
    Miller, Catherine
    Zhou, Ying
    Zhang, Meng
    Chyla, Brenda
    Potluri, Jalaja
    Dinardo, Courtney D.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (04) : 615 - 624
  • [5] CYP3A inhibitors and impact of these agents on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine on the VIALE-A study
    Jonas, Brian A.
    Dinardo, Courtney D.
    Fracchiolla, Nicola
    Pristupa, Alexander
    Ishizawa, Kenichi
    Jin, Jie
    Konopleva, Marina
    Ofran, Yishai
    Montesinos, Pau
    Kovacsovics, Tibor
    Jang, Jun-Ho
    Kantarjian, Hagop M.
    Hong, Wan-Jen
    Duan, Yinghui
    Ainsworth, William
    Potluri, Jalaja
    Werner, Michael
    Svensson, Anders Erik
    Pratz, Keith W.
    BLOOD, 2020, 136
  • [6] Use of CYP3Ai and impact on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine in the VIALE-A study
    Jonas, Brian A.
    DiNardo, Courtney
    Fracchiolla, Nicola
    Pristupa, Alexander
    Ishizawa, Kenichi
    Jin, Jie
    Konopleva, Marina
    Ofran, Yishai
    Montesinos, Pau
    Kovacsovics, Tibor
    Jang, Jun-Ho
    Kantarjian, Hagop
    Duan, Yinghui
    Potluri, Jalaja
    Werner, Michael
    Pratz, Keith W.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (11) : E422 - E425
  • [7] Long-Term Follow-up of the Phase 3 Viale-a Clinical Trial of Venetoclax Plus Azacitidine for Patients with Untreated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
    Pratz, Keith W.
    Jonas, Brian A.
    Pullarkat, Vinod A.
    Thirman, Michael J.
    Garcia, Jacqueline S.
    Fiedler, Walter
    Yamamoto, Kazuhito
    Wang, Jianxiang
    Yoon, Sung-Soo
    Wolach, Ofir
    Jang, Jun-Ho
    Yeh, Su-Peng
    Ku, Grace
    Zhou, Ying
    Chyla, Brenda
    Potluri, Jalaja
    DiNardo, Courtney D.
    BLOOD, 2022, 140
  • [8] Venetoclax in acute myeloid leukemia
    Bruzzese, Antonella
    Martino, Enrica Antonia
    Mendicino, Francesco
    Lucia, Eugenio
    Olivito, Virginia
    Neri, Antonino
    Morabito, Fortunato
    Vigna, Ernesto
    Gentile, Massimo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (04) : 271 - 276
  • [9] Venetoclax in Acute Myeloid Leukemia
    Mihaila, Romeo G.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2023, 18 (01) : 11 - 28
  • [10] Unmodified Dose of Azacitidine Plus Venetoclax Regimen without Drug Interactions during the First Cycle Leads to Similar Outcomes between Viale-a Clinical Trial and Real-Life in Acute Myeloid Leukemia
    Sedaki, Bochra
    Iat, Alexandre
    Loschi, Michael
    Benachour, Sami
    Chiche, Edmond
    Ryffel, Lea
    Brugel, Patricia
    Sudaka, Isabelle
    Aquaronne, Daniele
    Ferrero, Corinne
    Dadone, Berengere
    Cluzeau, Thomas
    BLOOD, 2022, 140 : 11718 - 11719
12345